AIA Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$332K Buy
5,512
+1,262
+30% +$76K 0.08% 129
2020
Q2
$250K Buy
4,250
+330
+8% +$19.7K 0.06% 101
2020
Q1
$219K Hold
3,920
0.05% 93
2019
Q4
$252K Buy
3,920
+691
+21% +$39.6K 0.32% 44
2019
Q3
$164K Buy
+3,229
New +$152K 0.16% 74

Other funds holding BMY

AIA Investment Management's BMY Position: Q3 2020 in Review

AIA Investment Management increased its Bristol-Myers Squibb (BMY) stake by 30% in Q3 2020, buying an estimated $76K and bringing the position to 5,512 shares worth $332K. The position accounts for 0.08% of the portfolio, ranked #129.

AIA Investment Management first reported a position in BMY in Q3 2019 and has held it in 5 quarters since. 2,214 funds tracked by Wall St. Rank hold BMY as of Q3 2020.

  • AIA Investment Management held 5,512 shares of Bristol-Myers Squibb worth $332K as of Q3 2020.
  • AIA Investment Management bought 1,262 Bristol-Myers Squibb shares in Q3 2020, an estimated $76K.
  • Bristol-Myers Squibb made up 0.08% of AIA Investment Management's portfolio in Q3 2020, its #129 holding.
  • AIA Investment Management first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 5 quarters since.
  • 2,214 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.